GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PetVivo Holdings Inc (OTCPK:PETV) » Definitions » Sloan Ratio %

PETV (PetVivo Holdings) Sloan Ratio % : -94.60% (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is PetVivo Holdings Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

PetVivo Holdings's Sloan Ratio for the quarter that ended in Dec. 2024 was -94.60%.

Warning Sign:

When sloan ratio (-103.56)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Dec. 2024, PetVivo Holdings has a Sloan Ratio of -94.60%, indicating earnings are more likely to be made up of accruals.


PetVivo Holdings Sloan Ratio % Historical Data

The historical data trend for PetVivo Holdings's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PetVivo Holdings Sloan Ratio % Chart

PetVivo Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -290.82 -310.90 -8.85 -61.50 -103.56

PetVivo Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -83.61 -103.63 -105.43 -76.72 -94.60

Competitive Comparison of PetVivo Holdings's Sloan Ratio %

For the Medical Devices subindustry, PetVivo Holdings's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PetVivo Holdings's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where PetVivo Holdings's Sloan Ratio % falls into.



PetVivo Holdings Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

PetVivo Holdings's Sloan Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2024 )-Cash Flow from Operations (A: Mar. 2024 )
-Cash Flow from Investing (A: Mar. 2024 ))/Total Assets (A: Mar. 2024 )
=(-10.955--7.42
--0.309)/3.115
=-103.56%

PetVivo Holdings's Sloan Ratio for the quarter that ended in Dec. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2024 )
=(-8.63--5.615
--0.071)/3.112
=-94.60%

PetVivo Holdings's Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was -2.651 (Mar. 2024 ) + -2.047 (Jun. 2024 ) + -2.175 (Sep. 2024 ) + -1.757 (Dec. 2024 ) = $-8.63 Mil.
PetVivo Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was -1.524 (Mar. 2024 ) + -1.53 (Jun. 2024 ) + -1.6 (Sep. 2024 ) + -0.961 (Dec. 2024 ) = $-5.62 Mil.
PetVivo Holdings's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 was -0.029 (Mar. 2024 ) + -0.015 (Jun. 2024 ) + -0.003 (Sep. 2024 ) + -0.024 (Dec. 2024 ) = $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PetVivo Holdings  (OTCPK:PETV) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2024, PetVivo Holdings has a Sloan Ratio of -94.60%, indicating earnings are more likely to be made up of accruals.


PetVivo Holdings Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of PetVivo Holdings's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


PetVivo Holdings Business Description

Traded in Other Exchanges
N/A
Address
5151 Edina Industrial Boulevard, Suite 575, Edina, MN, USA, 55439
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
Executives
John Lai director, 10 percent owner, officer: CEO 12100 SINGLETREE LANE, SUITE 186, EDEN PRAIRIE MN 55344
James Rudolph Martin director POBOX 53988, IRVINE CA 92619
A.l. Sarroff Fund, Llc 10 percent owner 43 MEADOW WOODS ROAD, GREAT NECK NY 11020
John Spencer Breithaupt director 3041 W. PASADENA DR., BOISE ID 83705
Robert J Costantino director 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joseph William Jasper director 201 SOUTH 11TH STREET, UNIT 1030, MINNEAPOLIS MN 55403
Robert James Rudelius director 6913 ARBOR LANE, MCCLEAN VA 22101
Leslie Anne Coolidge director 345 OLD SUTTON ROAD, BARRINGTON HILLS IL 60010
Robert J. Folkes officer: Chief Financial Officer 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Scott Mitchell Johnson director 475 LAKESHORE UNIT #32, INCLINE VILLAGE NV 89451
James Joseph Martin director 4400 BISCAYNE BLVD, SUITE # 670, MIAMI FL 33157
Gregory D Cash director
John Michael Carruth officer: Acting Chief Financial Officer 4923 RIVER WOOD DR., SAVAGE MN 55439
Sherry Grisewood director 377 FAIRMOUNT ROAD, CALIFON NJ 07830
David Don Deming director 16200 45TH STREET SOUTH, AFTON MN 55001